Quant ELSS Tax Saver Fund
The scheme aims to generate capital appreciation by investing predominantly in equity shares with growth potential. The secondary objective is to give dividend and other income.
Growthvine rating: 2/5 — ranked #31 of 57 in category.
Fund basics
| Category | Equity: ELSS |
|---|
| NAV | ₹384.25 (as of 2026-10-22) |
|---|
| AUM | ₹13,458 Cr |
|---|
| Expense ratio | 1.47% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Ayusha Kumbhat |
|---|
| Exit load | 0 |
|---|
Performance & risk
| 5-year annualised return | 13.11% |
|---|
| Sharpe ratio | 0.45 |
|---|
| Standard deviation | 18.30% |
|---|
| Max drawdown | −67.91% |
|---|
| Alpha | 3.54 |
|---|
| Beta | 1.07 |
|---|
Over 5 years, captured 114.9% of Nifty 500's upside and 96.5% of its downside.
Market cap allocation
| Large cap | 67.7% |
|---|
| Mid cap | 25.7% |
|---|
| Small cap | 6.5% |
|---|
Concentration
| Top 5 holdings | 39.4% |
|---|
| Top 10 holdings | 60.8% |
|---|
| Total holdings | 33 |
|---|
| Index overlap | 12.3% |
|---|
| Active share | 87.7% |
|---|
Top holdings
- TREPS 01-Oct-2026 DEPO 10 — 10.5%
- Samvardhana Motherson International Limited — 9.4%
- Adani Power Limited — 9.1%
- Aurobindo Pharma Ltd. — 8.5%
- ICICI Prudential Asset Management Company Limited — 7.6%
- LG Electronics India Limited — 4.9%
- Adani Green Energy Limited — 4.8%
- Tata Power Co. Ltd — 4.4%
- Bharti Airtel Ltd. — 4.2%
- Divis Laboratories Ltd. — 4.1%
Top sectors
- Energy — 22.2%
- Pharma & Biotech — 15.2%
- Cash — 10.7%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 2.0% | Q1 (Top) | #3 of 52 |
| 2025 | 6.7% | Q1 (Top) | #12 of 51 |
| 2024 | 9.3% | Q4 (Bottom) | #49 of 51 |
| 2023 | 30.4% | Q2 | #21 of 48 |
| 2022 | 12.3% | Q1 (Top) | #2 of 43 |